Eyes in Europe
Why Bristol-Myers Squibb invested in LSP's latest European life sciences fund
Bristol-Myers Squibb Co. (NYSE:BMY) is banking on LSP's expertise in early stage European investing to give the pharma access to emerging technologies and companies on the Continent.
For its first-ever investment in a European healthcare fund, the pharma put an undisclosed amount into LSP 5. While LSP